In this free webinar, learn about the key considerations for instrument selection, data quality assurance and innovative enabling technologies for evaluating Parkinsonian symptoms. Attendees will learn how to select and manage fit-for-purpose digital and conventional assessment options. The featured speakers will share options to improve the quality of data captured via strategic rater training and monitoring. Attendees will gain insights into leveraging precision motion sensor technology to discover meaningful and functional insights on patient motor function.
TORONTO, April 5, 2023 /PRNewswire-PRWeb/ -- This webinar will discuss key considerations for instrument selection, data quality assurance and innovative enabling technologies for evaluating Parkinsonian symptoms.
People with Parkinson's disease or parkinsonian conditions suffer from a range of symptoms, the most apparent of which may be motor impairment. However, efforts to explore meaningfulness to patients have resulted in recent drug development efforts also seeking to address non-motor symptoms. In Parkinson's Disease, Parkinson's disease Dementia (PDD) and Parkinsonian disorders such as Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD) and Dementia with Lewy Bodies (DLB), it is important to evaluate the impact of a range of Parkinsonian symptom domains — including cognitive or behavioral impairment — and to understand how these may relate to motor symptoms.
To better answer important questions about the safety and efficacy of therapeutic candidates for people with Parkinson's disease and atypical Parkinsonian disorders, fit-for-purpose assessments are critical to evaluate the full range of symptom domains to gather a complete picture of an individual's condition.
In this webinar, hear from Clario and Cogstate scientists as they offer guidance on effective digital and conventional assessment options, tactics to improve the quality of data via strategic rater training and monitoring and describe how to leverage precision motion sensor technology to discover meaningful and functional insights on patient motor function.
The webinar will also include regulatory considerations, such as acceptance, recent digital health technology guidance and approval pathway selection for clinical outcome assessments or biomarker endpoints.
Join this webinar to learn how digital assessments and enabling technologies help gain a comprehensive understanding of Parkinsonian symptoms, reflective of importance to patients, across motor, cognitive & behavioral impairments.
Join Chris Edgar, PhD, Chief Science Officer, Cogstate; Lisle Kingery, PhD, Senior Principal Scientist, Cogstate; and Kristen Sowalsky, DC, PhD, VP Medical & Scientific Affairs, Precision Motion, Clario, for the live webinar on Wednesday, April 26, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Parkinsonian Symptoms — Capturing a Comprehensive Picture with Fit-for-Purpose Assessments.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article